PAM
CYCN icon

Panagora Asset Management’s Cyclerion Therapeutics CYCN Stock Holding History

Panagora Asset Management’s Portfolio CYCN Stock Details CYCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-70
Closed -$5K – 1883
2021
Q2 		$5K Hold
70
– – ﹤0.01% 2480
2021
Q1 		$4K Sell
70
-20
-22% -$1.5K ﹤0.01% 2618
2020
Q4 		$6K Sell
90
-6
-6% -$409 ﹤0.01% 2409
2020
Q3 		$12K Buy
+96
New +$11K ﹤0.01% 2295
2020
Q2 		– Sell
-1
Closed – – 2580
2020
Q1 		$0 Sell
1
-11,659
-100% -$832K ﹤0.01% 2527
2019
Q4 		$634K Sell
11,660
-83
-0.7% -$7.75K ﹤0.01% 1221
2019
Q3 		$2.85M Buy
11,743
+3,257
+38% +$704K 0.01% 630
2019
Q2 		$1.94M Buy
+8,486
New +$2.4M 0.01% 846

Other funds holding CYCN

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Panagora Asset Management's CYCN Position: Q3 2021 in Review

Panagora Asset Management sold out of Cyclerion Therapeutics (CYCN) in Q3 2021, closing a stake of 70 shares — an estimated $5K sold.

Panagora Asset Management first reported a position in CYCN in Q2 2019 and held it in 8 quarters. The position peaked at $2.85M in Q3 2019. 61 funds tracked by Wall St. Rank hold CYCN as of Q3 2021.

  • Panagora Asset Management reported no remaining Cyclerion Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Panagora Asset Management sold 70 Cyclerion Therapeutics shares in Q3 2021, an estimated $5K.
  • Panagora Asset Management first reported a position in Cyclerion Therapeutics in Q2 2019 and held it in 8 quarters.
  • Panagora Asset Management's Cyclerion Therapeutics position peaked at $2.85M in Q3 2019.
  • 61 funds tracked by Wall St. Rank held Cyclerion Therapeutics as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.